Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
QNCX | US
-0.03
-3.19%
Healthcare
Biotechnology
30/06/2024
17/10/2024
0.79
0.82
0.82
0.76
Quince Therapeutics Inc. a preclinical stage biopharmaceutical company develops precision therapeutics for debilitating and rare diseases. Its lead compound is NOV004 a systemically administered bone anabolic peptide engineered to target and concentrate at bone fracture sites. The company was formerly known as Cortexyme Inc. and changed its name to Quince Therapeutics Inc. in August 2022. Quince Therapeutics Inc. was incorporated in 2012 and is headquartered in South San Francisco California.
View LessLow Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
98.7%1 month
92.1%3 months
73.0%6 months
72.0%-
-
0.64
0.31
0.11
1.44
-
-
-29.13M
34.31M
34.31M
-
-
-
-
-79.38
20.83
4.80
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.14
Range1M
0.18
Range3M
0.36
Rel. volume
0.55
Price X volume
28.86K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
BioLineRx Ltd | BLRX | Biotechnology | 0.462 | 36.93M | -1.70% | n/a | 223.55% |
Lantern Pharma Inc. | LTRN | Biotechnology | 3.39 | 36.49M | -3.14% | n/a | 0.71% |
Enlivex Therapeutics Ltd | ENLV | Biotechnology | 1.63 | 34.89M | -3.55% | n/a | 2.92% |
OKYO Pharma Limited | OKYO | Biotechnology | 1.01 | 34.17M | -3.81% | n/a | -107.88% |
OCUP | OCUP | Biotechnology | 1.27 | 33.54M | -0.78% | n/a | 0.00% |
Moolec Science SA Ordinary Shares | MLEC | Biotechnology | 0.89 | 33.34M | -3.26% | n/a | 209.19% |
Dyadic International Inc | DYAI | Biotechnology | 1.13 | 33.31M | -2.59% | n/a | 175.64% |
Acasti Pharma Inc | ACST | Biotechnology | 3.2816 | 33.28M | -2.04% | n/a | 0.00% |
Acurx Pharmaceuticals Inc. Common Stock | ACXP | Biotechnology | 2.02 | 32.82M | -1.46% | n/a | 0.00% |
Curis Inc | CRIS | Biotechnology | 5.34 | 31.93M | 0.56% | n/a | -6039.91% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.44 | 0.53 | Expensive |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 0.64 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 72.99 | 72.92 | Par |
Debt to Equity | 0.31 | -1.24 | Expensive |
Debt to Assets | 0.11 | 0.25 | Cheaper |
Market Cap | 34.31M | 3.78B | Emerging |